MOTRIN COLD & SINUS CAPLETS 30 MG
PSEUDOEPHEDRINE HYDROCHLORIDE : 30 MG IBUPROFEN : 200 MG · DIN 02245685 · MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
Health Canada status: CANCELLED PRE MARKET
What is MOTRIN COLD & SINUS CAPLETS?
MOTRIN COLD & SINUS CAPLETS 30 MG contains PSEUDOEPHEDRINE HYDROCHLORIDE : 30 MG IBUPROFEN : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02245685, held by MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 09-Jan-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MOTRIN COLD & SINUS CAPLETS used for?
Temporary relief of symptoms associated with sinusitis, the common cold or flu including nasal congestion, headache, body aches, pains and fever.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02245685 |
|---|---|
| Brand name | MOTRIN COLD & SINUS CAPLETS |
| Generic / active ingredient | PSEUDOEPHEDRINE HYDROCHLORIDE : 30 MG IBUPROFEN : 200 MG |
| Manufacturer | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
| Strength | 30 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M01AE51 IBUPROFEN, COMBINATIONS |
| AHFS class | 84:06.00 ; 84:28.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 09-Jan-2020 |
| Original market date | 2002-05-03 00:00:00 |
How is it administered?
Adults and children 12 years and older: Take 1 or 2 caplets every 4 to 6 hours as needed. Do not exceed 6 caplets in 24 hours unless directed by a physician.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in provided text (refers to Storage and Stability section).
How is it supplied?
Not explicitly detailed in provided text (refers to Dosage Forms, Composition and Packaging section).
Contraindications
Hypersensitivity to ibuprofen, pseudoephedrine, or NSAIDs; ASA intolerance; active GI ulcer/bleeding; severe hepatic/renal impairment; pregnancy; hypertension; coronary artery disease; MAOI therapy.
Warnings and precautions
Risk of serious GI toxicity (bleeding, ulceration), cardiovascular events, renal toxicity, and serious skin reactions (Stevens-Johnson syndrome). Caution in patients with heart disease or diabetes.
What can be used instead?
Other Canadian products sharing ATC code M01AE51 IBUPROFEN, COMBINATIONS. 13 of 40 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ADVIL COLD & SINUS CONVENIENCE PACK | 2 MG | KIT ; TABLET | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | MARKETED | DIN 02399733 |
| ADVIL COLD & SINUS LIQUI-GELS | 200 MG | CAPSULE | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | MARKETED | DIN 02250705 |
| ADVIL COLD & SINUS PLUS | 30 MG | TABLET | HALEON CANADA ULC | MARKETED | DIN 02248645 |
| ADVIL COLD AND SINUS | 200 MG | TABLET | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | MARKETED | DIN 02036312 |
| ADVIL COLD AND SINUS DAYTIME | 200 MG | TABLET | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | MARKETED | DIN 02267616 |
| ADVIL COLD AND SINUS NIGHTTIME | 30 MG | TABLET | HALEON CANADA ULC | MARKETED | DIN 02267632 |
| ADVIL COLD, SINUS & FLU EXTRA STRENGTH | 4 MG | TABLET | HALEON CANADA ULC | MARKETED | DIN 02471604 |
| ADVIL FLU | 200 MG | CAPSULE | HALEON CANADA ULC | MARKETED | DIN 02401193 |
| ADVIL NIGHTTIME | 200 MG | CAPSULE | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | MARKETED | DIN 02355841 |
| COLD + SINUS | 200 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02352281 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.